Reconova Technologies Timeline
Overview
Funding
Financials
Discovery
Timeline
Events
2026-07-08 - Market Signal - Reconova begins trading on HKEX as 07656.HK
- HKEX listed RECONOVA as a new security on 8 July 2026 under stock code 07656. Reconova works across vision AI, VLA models and embodied composite robots. The listing adds a public-market signal for a China-based embodied-AI and robot-vision company. -
source: hkex.com.hk
2026-06-30 - Market Signal - Reconova launches Hong Kong IPO under 7656.HK
- The offering covers 28.087 million H-shares priced at HK$21.66 per share. Reconova is an embodied vision intelligence supplier rather than a robot OEM. The transaction changes the company capital base, ownership structure or strategic reach for… -
source: news.google.com
2025-08-22 - Funding - Reconova closes Series E at CNY3.55B post-money
- Issuer prospectus states pre-money valuation of CNY3500000000 and post-money valuation of CNY3550000000. Primary consideration treatment: CNY50M aggregate August 2025 primary subscriptions; the April and August 2025 secondary transfers are excluded.… -
source: www1.hkexnews.hk
2022-09-05 - Funding - Reconova closes Series D at CNY2.619B post-money
- Issuer prospectus states pre-money valuation of CNY2500000000 and post-money valuation of CNY2619000000. Primary consideration treatment: CNY119M aggregate primary subscriptions; CNY80M of separately listed secondary transfers are excluded. Investors: Ningbo… -
source: www1.hkexnews.hk
2021-03-11 - Funding - Reconova closes Series C+ at CNY2.06B post-money
- Issuer prospectus states pre-money valuation of CNY2000000000 and post-money valuation of CNY2060000000. Primary consideration treatment: CNY60M primary subscription; separately listed February 2021 share transfers are excluded. Investors: Shanghai Shi Chuan… -
source: www1.hkexnews.hk
2020-12-29 - Funding - Reconova closes Series C at CNY2.0B post-money
- Issuer prospectus states pre-money valuation of CNY1800000000 and post-money valuation of CNY2000000000. Primary consideration treatment: CNY191,176,471 aggregate primary consideration shown for investors retained in the filing table; investors who ceased to… -
source: www1.hkexnews.hk
2019-11-25 - Funding - Reconova closes Pre-C at CNY1.2B post-money
- Issuer prospectus states pre-money valuation of CNY1026000000 and post-money valuation of CNY1200000000. Primary consideration treatment: CNY60M primary subscription retained in the filing table; investors who ceased to be shareholders are excluded.… -
source: www1.hkexnews.hk
2018-03-15 - Funding - Reconova closes Series B+ at CNY500M post-money
- Issuer prospectus states pre-money valuation of CNY465000000 and post-money valuation of CNY500000000. Primary consideration treatment: CNY35M Intel primary cash subscription; Su Xiaosheng's later non-cash contribution of Beijing Deep Sense equity is… -
source: www1.hkexnews.hk
2018-02-02 - Funding - Reconova closes Series B at CNY400M post-money
- Issuer prospectus states pre-money valuation of CNY350000000 and post-money valuation of CNY400000000. Primary consideration treatment: CNY50M aggregate primary subscriptions retained in the filing table. Investors: Wuxi ST Zhihang (SWLVC), Shihezi Shangshi… -
source: www1.hkexnews.hk
2016-07-26 - Funding - Reconova closes Series A at CNY139M post-money
- Issuer prospectus states pre-money valuation of CNY110000000 and post-money valuation of CNY139000000. Primary consideration treatment: CNY7.5M convertible loan converted to equity plus CNY6M cash subscription; the filing table excludes investors who later… -
source: www1.hkexnews.hk
View Reconova Technologies overview